1. |
Pepper MS, Tille JC, Nisato R, et al. Lymphangiogenesis and tumor metastasis [J]. Cell Tissue Res, 2003; 314(1)∶167.
|
2. |
Folkman J, Kaipainen A. Genes tell lymphatics to sprout or not [J]. Nat Immunol, 2004; 5(1)∶11.
|
3. |
Schneider M, Büchler P, Giese N, et al. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread [J]. Int J Oncol, 2006; 28(4)∶883.
|
4. |
Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics [J]. Science, 2002; 296(5574)∶1883.
|
5. |
Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [J]. Science, 1997; 276(5317)∶1423.
|
6. |
Jones A, Fujiyama C, Turner K, et al. Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis [J]. BJU Int, 2000; 86(1)∶80.
|
7. |
Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer [J]. Eur J Cancer, 2001; 37(7)∶918.
|
8. |
Valtola R, Salven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer [J]. Am J Pathol, 1999; 154(5)∶1381.
|
9. |
敬静, 李宏江, 朱炜炜, 等. 乳腺疾病中血管内皮生长因子的表达及其意义[J]. 中国普外基础与临床杂志, 2001; 8(5)∶322.
|
10. |
Liersch R, Nay F, Lu L, et al. Induction of lymphatic endothelial cell differentiation in embryoid bodies [J]. Blood, 2006; 107(3)∶1214.
|
11. |
Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype [J]. EMBO J, 2002; 21(7)∶1505.
|
12. |
Witmer AN, van Blijswijk BC, Dai J, et al. VEGFR-3 in adult angiogenesis [J]. J Pathol, 2001; 195(4)∶490.
|
13. |
Ny A, Koch M, Schneider M, et al. A genetic Xenopus laevis tadpole model to study lymphangiogenesis [J]. Nat Med, 2005; 11(9)∶998.
|
14. |
Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation [J]. Nature, 2000; 407(6801)∶242.
|
15. |
Makinen T, Veikkola T, Mustjoki S, et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 [J]. EMBO J, 2001; 20(17)∶4762.
|
16. |
Stacker SA, Stenvers K, Caesar C, et al. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers [J]. J Biol Chem, 1999; 274(45)∶32127.
|
17. |
Tsai PW, Shiah SG, Lin MT, et al. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway [J]. J Biol Chem, 2003; 278(8)∶5750.
|
18. |
Su JL, Shih JY, Yen ML, et al. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma [J]. Cancer Res, 2004; 64(2)∶554.
|
19. |
Tang RF, Wang SX, Zhang FR, et al. Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer [J].Hepatobiliary Pancreat Dis Int, 2005; 4(3)∶460.
|
20. |
Jenny B, Harrison JA, Baetens D, et al. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas [J]. J Pathol, 2006; 209(1)∶34.
|
21. |
Liao X, Tang W, Cai Q, et al. Lymphangiogenesis in tumor tissues and 5’-nase, Flt-4, Flk-1 expressions [J]. Chin Med J (Engl), 2000; 113(11)∶1031.
|
22. |
Kubo H, Cao R, Brakenhielm E, et al. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea [J]. Proc Natl Acad Sci USA, 2002; 99(13)∶8868.
|
23. |
王天宝, 董文广, 韩方海, 等. 血管内皮生长因子受体-3与胃癌临床病理因素的关系 [J]. 中国普外基础与临床杂志, 2004; 11(4)∶341.
|
24. |
Saharinen P, Tammela T, Karkkainen MJ, et al. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation [J]. Trends Immunol, 2004; 25(7)∶387.
|
25. |
Nathanson SD. Insights into the mechanisms of lymph node metastasis [J]. Cancer, 2003; 98(2)∶413.
|
26. |
McCarthy DM, Hruban RH, Argani P, et al. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases [J]. Mod Pathol, 2003; 16(3)∶272.
|
27. |
Kaliski A, Maggiorella L, Cengel KA, et al. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion [J]. Mol Cancer Ther, 2005; 4(11)∶1717.
|
28. |
Onogawa S, Kitadai Y, Tanaka S, et al. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma [J]. Cancer Sci, 2004; 95(1)∶32.
|
29. |
Krishnan J, Kirkin V, Steffen A, et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats [J]. Cancer Res, 2003; 63(3)∶713.
|
30. |
Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis [J]. Cancer Cell, 2005; 7(2)∶121.
|
31. |
Matsumoto K, Konno H, Tanaka T, et al. Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft [J]. Jpn J Cancer Res, 2000; 91(7)∶748.
|
32. |
Wroel T, Mazur G, Dziegiel P, et al. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes [J]. Folia Histochem Cytobiol, 2006; 44(1)∶43.
|
33. |
He Y, Rajantie I, Pajusola K, et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels [J]. Cancer Res, 2005; 65(11)∶4739.
|